The estimated Net Worth of (Reynolds) Marie C Infante is at least $292 Thousand dollars as of 7 September 2021. Ms. Infante owns over 359 units of OrthoPediatrics corp stock worth over $154,222 and over the last 6 years she sold KIDS stock worth over $56,885. In addition, she makes $80,786 as Independent Director at OrthoPediatrics corp.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Ms. Infante KIDS stock SEC Form 4 insiders trading
Marie has made over 2 trades of the OrthoPediatrics corp stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 359 units of KIDS stock worth $24,839 on 7 September 2021.
The largest trade she's ever made was selling 700 units of OrthoPediatrics corp stock on 16 March 2021 worth over $32,046. On average, Marie trades about 118 units every 19 days since 2018. As of 7 September 2021 she still owns at least 4,943 units of OrthoPediatrics corp stock.
You can see the complete history of Ms. Infante stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Marie Infante biography
Marie C. Infante serves as Independent Director of the Company. Ms. Infante was nominated pursuant to the Stockholders’ Agreement with Squadron Capital LLC. Her prior experience as a director includes educational, non-profit, and professional organizations. Ms. Infante has more than 25 years of experience as a healthcare lawyer and a certified compliance professional. Since 2013, she has been an active consultant and senior advisor in the healthcare industry. Recent affiliations have included Avalon Healthcare Services, Zimmet Healthcare Services Group, Triple Tree Capital Partners and BDO Center for Healthcare Excellence and Innovation. From 2006 to 2013, she served as the Senior Vice President, Chief Compliance Officer and General Counsel for Healthcare Law for a $3 billion leader in post-acute heathcare services whose 42,000 employees cared for over 60,000 patients annually. Her industry expertise also stems from 15 years as a clinical specialist in orthopedic nursing. Ms. Infante is a graduate of the University of Maryland, where she earned a Bachelor of Science in Nursing and a Master of Science. She also holds an MBA from Loyola University and a JD from the Catholic University of America.
What is the salary of Marie Infante?
As the Independent Director of OrthoPediatrics corp, the total compensation of Marie Infante at OrthoPediatrics corp is $80,786. There are 11 executives at OrthoPediatrics corp getting paid more, with Mark Throdahl having the highest compensation of $1,190,150.
How old is Marie Infante?
Marie Infante is 70, she's been the Independent Director of OrthoPediatrics corp since 2014. There are 2 older and 16 younger executives at OrthoPediatrics corp. The oldest executive at OrthoPediatrics corp is Stephen Burns, 76, who is the Independent Director.
What's Marie Infante's mailing address?
's mailing address filed with the SEC is 2850 Frontier Dr, Warsaw, IN 46582, USA.
Insiders trading at OrthoPediatrics corp
Over the last 17 years, insiders at OrthoPediatrics corp have traded over $17,595,944 worth of OrthoPediatrics corp stock and bought 44,994 units worth $1,275,983 . The most active insiders traders include David R Pelizzon, John V. Schaefer, and Mark C Throdahl. On average, OrthoPediatrics corp executives and independent directors trade stock every 24 days with the average trade being worth of $158,746. The most recent stock trade was executed by Daniel J Gerritzen on 21 August 2024, trading 10,000 units of KIDS stock currently worth $293,000.
What does OrthoPediatrics corp do?
orthopediatrics is the worldwide leader in pediatric orthopedics. we are the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. every day, we focus purely on advancing the field of pediatric orthopedics through the innovative development of state-of-the-art technologies, commitment to quality products, and industry-leading support and clinical education with our experienced team of experts. our offering is continuing to expand as we strive to develop all of the necessary implants and instruments that a pediatric orthopedic surgeon needs to treat his/her patients, including: long bone deformity correction & trauma, spine, and sports medicine. as we continue to grow, we are looking for talented professionals to join our cause! visit our website to learn more about current openings, or submit a resume to careers@orthopediatrics.com!
What does OrthoPediatrics corp's logo look like?
Complete history of Ms. Infante stock trades at OrthoPediatrics corp
OrthoPediatrics corp executives and stock owners
OrthoPediatrics corp executives and other stock owners filed with the SEC include:
-
Mark Throdahl,
Chief Executive Officer, Director -
Fred Hite,
Chief Financial Officer, Chief Operating Officer, Director -
Gregory Odle,
Executive Vice President -
David Bailey,
President -
Daniel Gerritzen,
Vice President of Legal and Human Resources, General Counsel, Secretary -
Mark C. Throdahl,
Exec. Chairman -
Fred L. Hite,
CFO, Principal Financial & Accounting Officer, COO and Director -
David R. Bailey,
Pres, CEO & Director -
Gregory A. Odle,
Exec. VP of Commercialization -
Daniel J. Gerritzen,
Gen. Counsel & Sec. -
Terry Schlotterback,
Independent Chairman of the Board -
Marie Infante,
Independent Director -
Bryan Hughes,
Independent Director -
Kevin Unger,
Independent Director -
Samuel Riccitelli,
Independent Director -
Stephen Burns,
Independent Director -
Bernie Berry,
Independent Director -
Harald Ruf,
Director -
David Pelizzon,
Director -
Tram Bui,
IR Contact Officer -
Paul J. Mraz,
Sr. VP & GM of Scoliosis -
Mark Karshner,
Sr. VP of International Sales -
Joe Hauser,
Sr. VP & GM of Trauma & Deformity Correction -
Dr. Peter F. Armstrong M.D.,
Chief Medical Officer & Chair of Surgeon Advisory Board -
Joel Batts,
Sr. VP of Science & Technology -
Jennifer N. Pritzker,
10% owner -
Frederick Hurley,
Senior VP Merchandising -
Craig Kimbrough Currie,
Senior VP My Twinn & BabyUnive -
Barry Hollingsworth,
Chief Financial Officer -
John V. Schaefer,
Director -
Edward John Ulbrich,
Director -
Michael J. Wagner,
Chief Executive Officer -
Christopher Cummings,
Senior VP & CIO -
Pamela Nadine Abrams,
Director -
Joseph Frank Rosales,
Director -
Direct Capital, L.L.C.D. E....,
-
John C Textor,
Director -
E. Shaw Laminar Acquisition...,
-
Harold Ruf,
Director -
George Sinclair Mitchell Dyer,
Director -
Joseph W Hauser,
Pres. Trauma & Def. Correction -
Capital Llc Squadron Capita...,
-
Jimmy Duane Mc Donald,
Director